NCT06487364Recruiting
Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8
Source: ClinicalTrials.gov · Last updated 5 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 39 (estimated)
- First submitted
- 27 Jun 2024
- Start date
- 13 May 2024
- Primary completion date
- 17 Jan 2025
- Lead sponsor
- Emre Şenocak
- Diseases
- Parkinson disease
- NCT number
- NCT06487364
What you commit to
- Study type: Observational
- Planned participants: 39
- From 13 May 2024 to the primary completion date, 17 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any surgery and/or trauma affecting the upper extremity
- Those who use alcohol and drugs;
Other illness
- Having a secondary neurological disease;
Other
- Having complaints of pain before the treatment program;
- There was a change in medical treatment during the study;
- With symptoms of anxiety and depression;
- Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss
Who the study is looking for
- Having regular neurology follow-up and using medicine;
- Hoehn and Yahr Scale Stage between 1-3 points;
- Mini-Mental State Assessment Score \>24 points;
Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Private Güney Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.